In addition Ellen Degeneres leading pharmaceutical andbiotechnology companies

In addition, analyzes ellen degeneres show leading pharmaceutical ellendegeneres show examines andbiotechnology companies collaborate with Array to discover and develop drugcandidates across a broad range of therapeutic areas. For more information onArray, please go to Forward-Looking StatementThis press release contains forward-looking statements within the meaning of thePrivate Securities Litigation Reform Act of 1995, including statements about ourfuture plans for advancing certain of our proprietary drug programs, thepotential to earn future milestone payments, license fees or royalty revenue,and the plans of our collaborators to further develop drugs we have out-licensedor on which we are collaborating. These statements involve significant risks anduncertainties, including those discussed in our annual report filed on form 10-Kfor the year ended June 30, 2008, and in other reports filed by Array with theSecurities and Exchange Commission. Because these statements reflect our currentexpectations concerning future events, our actual results could differmaterially from those anticipated in these forward-looking statements as aresult of many factors. These factors include, but are not limited to, ourability to continue to fund and successfully progress internal research effortsand to create effective, commercially viable drugs, our ability to achieve andmaintain profitability, the extent to which the pharmaceutical and biotechnologyindustries are willing to in-license drug candidates for their product pipelinesand to collaborate with and fund third parties on their drug discoveryactivities, our ability to out-license our proprietary candidates on favorableterms, risks associated with our dependence on our collaborators for theclinical development and commercialization of our out-licensed drug candidates,the ability of our collaborators and of Array to meet objectives tied tomilestones and royalties, and our ability to attract and retain experiencedscientists and management We are providing this information as of January 9,2009. We undertake no duty to update any forward-looking statements to reflectthe occurrence of events or circumstances after the date of such statements orof anticipated or unanticipated events that alter any assumptions underlyingsuch statements.

Array BioPharma Inc.Tricia Haugeto, Copyright Business Wire 2009 Ellen Degeneres . Accredited monthly PPM data in Riverside are based on `Radio First` methodologyusing telephone sampling and recruitment procedures that include both landlineand cell-phone-only households.Arbitron remains committed to MRC accreditation in all PPM markets.NEW YORK--(Business Wire)--Arbitron Inc ellen show . (NYSE: ARB) announced today that the Media Rating Council (MRC)has accredited the Arbitron Portable People MeterTM radio quarter hour ratingsdata in Riverside-San Bernardino ellen tv show . "The accreditation of the monthly PPMTM quarter hour radio estimates inRiverside-San Bernardino demonstrates that our `Radio First` methodology, whichuses a telephone-based sample frame and telephone recruitment, can deliveraudience estimates that meet the standards of the Media Rating Council," saidSteve Morris, chairman, president and chief executive officer, Arbitron Inc."Our goal now is to demonstrate that the sample quality initiatives we havecommitted to for all our PPM markets will have a continuing positive impact,just as they have had in Riverside-San Bernardino." "Our commitment to MRC accreditation means a commitment to continuousimprovement," said Mr Morris ellen .

"In Riverside-San Bernardino, we are continuingto work with the MRC on enhancing the quality of the sample." The PPM radio estimates in Riverside are based on Arbitron`s `Radio First` PPMmethodology, which uses a telephone-based sampling and recruitment methodologyand includes both landline and cell-phone-only households . The MRC has accredited the monthly quarter hour radio ratings data inRiverside-San Bernardino, which are the "buy-sell" currency data for PPMmarkets degeneres . Arbitron has not submitted weekly and minute-by-minute PPM data for MRCaccreditation ellen portia . Investor Call: Schedule and AccessArbitron will host a conference call at 4:30 p.m . Eastern Time on Monday,January 12, 2009 to discuss the accreditation of the PPM service inRiverside-San Bernardino, the recently announced settlements with the New Yorkand New Jersey Attorneys General and other matters. The Company invites you to listen to the call by dialing (toll free) (888)562-3356.